World125_Task01_NA

Using the 2024 annual report, identify whether Impact Therapeutics sells primarily branded drugs. A company sells primarily branded drugs if the majority of drugs have launch dates within the last 7 years.

Please use the BCG report to determine the average COGS as a % of revenue for competitors in Impact Therapeutics' segment, based on whether they sell primarily generic drugs, branded, or a mix. Round to the nearest %. In both the global and US geos, state whether Impact Therapeutics is above ...

Based on the information you have given me:

1. Impact Therapeutics is a company that primarily sells branded drugs.
2. The average of COGS as a share of revenue for companies that primarily sell branded drugs is 23%.
3. Both the global COGS and the US COGS, as a share of revenue, for Impact Therapeutics in 2024 are higher than the average of 23%.